XML 42 R6.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Consolidated Statements of Cash Flows (USD $)
In Millions
6 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Cash flows from operating activities:    
Net earnings $ 674 $ 1,217
Adjustments to reconcile net earnings to net cash provided by operating activities:    
Change in receivables and advance premiums 926 423
Increase in deferred policy acquisition costs (225) (164)
Increase in policy liabilities 1,922 1,473
Change in income tax liabilities (82) 181
Realized investment (gains) losses 1,247 135
Other, net (84) (242)
Net cash provided (used) by operating activities 4,378 3,023
Securities available for sale:    
Fixed maturities sold 1,767 1,055
Fixed maturities matured or called 775 312
Perpetual securities sold 226 582
Perpetual securities matured or called 61 0
Equity securities sold 0 328
Securities held to maturity:    
Fixed maturities matured or called 325 2
Securities available for sale:    
Fixed maturities acquired (4,822) (4,606)
Equity securities acquired 0 (330)
Securities held to maturity:    
Fixed maturities acquired (3,484) (642)
Cash received as collateral on loaned securities, net 147 134
Other, net (29) (11)
Net cash provided (used) by investing activities (5,034) (3,176)
Cash flows from financing activities:    
Purchases of treasury stock (222) (5)
Principal payments under debt obligations (1) (2)
Dividends paid to shareholders (260) (262)
Change in investment-type contracts, net 275 191
Treasury stock reissued 26 36
Other, net 7 35
Net cash provided (used) by financing activities (175) (7)
Effect of exchange rate changes on cash and cash equivalents 1 21
Net change in cash and cash equivalents (830) (139)
Cash and cash equivalents, beginning of period 2,121 2,323
Cash and cash equivalents, end of period 1,291 2,184
Supplemental disclosures of cash flow information:    
Income taxes paid 460 532
Interest paid 72 52
Impairment losses included in realized investment losses 933 42
Noncash financing activities:    
Capitalized lease obligations 1 1
Treasury stock issued for:    
Shareholder dividend reinvestment 21 0
Share-based compensation grants $ 2 $ 3